Does CABOZANTINIB S-MALATE Cause Product prescribing issue? 294 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 294 reports of Product prescribing issue have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.8% of all adverse event reports for CABOZANTINIB S-MALATE.
294
Reports of Product prescribing issue with CABOZANTINIB S-MALATE
0.8%
of all CABOZANTINIB S-MALATE reports
8
Deaths
34
Hospitalizations
How Dangerous Is Product prescribing issue From CABOZANTINIB S-MALATE?
Of the 294 reports, 8 (2.7%) resulted in death, 34 (11.6%) required hospitalization, and 2 (0.7%) were considered life-threatening.
Is Product prescribing issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB S-MALATE. However, 294 reports have been filed with the FAERS database.
What Other Side Effects Does CABOZANTINIB S-MALATE Cause?
Diarrhoea (8,282)
Fatigue (6,819)
Off label use (5,245)
Nausea (4,341)
Decreased appetite (4,076)
Blood pressure increased (2,939)
Malignant neoplasm progression (2,718)
Palmar-plantar erythrodysaesthesia syndrome (2,706)
Weight decreased (2,657)
Stomatitis (2,560)
What Other Drugs Cause Product prescribing issue?
DUPILUMAB (1,715)
POLYETHYLENE GLYCOL 3350 (1,439)
LENALIDOMIDE (948)
OXYCODONE (646)
RIVAROXABAN (359)
ACETAMINOPHEN\OXYCODONE (347)
ETONOGESTREL (311)
ACETAMINOPHEN\HYDROCODONE (298)
CERTOLIZUMAB PEGOL (297)
MORPHINE (288)
Which CABOZANTINIB S-MALATE Alternatives Have Lower Product prescribing issue Risk?
CABOZANTINIB S-MALATE vs CAFFEINE
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB S-MALATE vs CALCIFEDIOL
CABOZANTINIB S-MALATE vs CALCIPOTRIENE